Back to results
US 10,864,208 B2Granted
Ophthalmic composition
AssigneeSydnexis, Inc.
InventorsGregory I. Ostrow, Kenneth J. Widder, David S. Baker
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSydnexis, Inc.
InventorsGregory I. Ostrow, Kenneth J. Widder, David S. Baker
Estimating the term…
Provided herein is an ophthalmic composition. In some embodiments, the ophthalmic composition includes a low concentration of an ophthalmic agent for treatment of an ophthalmic disorder or condition; and an ophthalmically acceptable carrier, wherein the ophthalmic agent is distributed with substantial uniformity throughout the ophthalmically acceptable carrier. Further disclosed herein include an ophthalmic composition including a low concentration of an ophthalmic agent and deuterated water. Also disclosed herein are methods of arresting or preventing myopia development by administering to an eye of an individual in need thereof an effective amount of an ophthalmic composition as described herein.
An ophthalmic composition comprising about 0.01% w/v of atropine or its pharmaceutically acceptable salt and deuterated water, at a pD of from about 5 to about 7.
An ophthalmic composition comprising about 0.03% w/v of atropine or its pharmaceutically acceptable salt and deuterated water, at a pD of from about 5 to about 7.
Dependencies are inferred from the claim text.